(Aurora, Ontario) – December 4, 2014 — Helix BioPharma Corp. (TSX, FSE: “HBP”), a
biopharmaceutical company developing innovative drug candidates for the prevention and
treatment of cancer, today announced that the Company has begun a comprehensive exploration
of growth opportunities available to it.
- 0 Comments
- FY2015